Concepedia

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

Cheryl Lin, Meredith Buxton, Dan H. Moore, Helen Krontiras, Lisa A. Carey, Angela De Michele, Leslie L. Montgomery, Debasish Tripathy, Constance D. Lehman, Minetta C. Liu,

Breast Cancer Research and Treatment · 2011 · 30 citations · 23 references

DOI

Concepts

References

23

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations

, , +14

Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

Ellen Warner · JAMA · 2004 · 1.2K citations

, , +15

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Ingvar Andersson, Knut Aspegren, Lars Janzon et al. · BMJ · 1988 · 926 citations · Full text

, , +13

Ten- to Fourteen-Year Effect of Screening on Breast Cancer Mortality<xref ref-type="fn" rid="fn2">2</xref>

S Shapiro, Wanda Venet, Philip Strax et al. · JNCI Journal of the National Cancer Institute · 1982 · 842 citations

, , +16

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

AD Barker, C C Sigman, Kelloff Gj et al. · Clinical Pharmacology & Therapeutics · 2009 · 766 citations

, , +17